ScreenerHero

AB AB Science S.A.

EPA · FR · Healthcare · Drug Manufacturers - Specialty & Generic · ab-science.com
0.5370EUR-1.29%Mkt Cap: 56.34M $P/E: —

AB Science S.A., a clinical-stage company, engages in the research, design, development, and marketing of drugs to address pathologies affecting the peripheral and central nervous system, inflammatory diseases, and cance…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB
$14.24BUSDP/E 109.4
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.50BUSDP/E 18.4
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap56.34M USD
Enterprise Value53.32M USD
Revenue (TTM)1.28M USD
Gross Profit1.06M USD
Net Income (TTM)-1.69M USD
Revenue/Share0.02 EUR
Last Price0.5370 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees26
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINFR0010557264
Valuation
P/E (Trailing)—
P/E (Forward)-3.89
PEG—
EV/EBITDA65.84
EV/Revenue41.78
P/S44.73
P/B-2.31
EPS (TTM)-0.03
EPS (Forward)-0.14
52W Range
0.50103% of range1.680
52W High1.680 EUR
52W Low0.5010 EUR
Profitability
Gross Margin83.30%
Oper. Margin510.93%
EBITDA Margin63.46%
Profit Margin-132.62%
ROE9.05%
ROA-6.35%
Growth
Revenue Growth28.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.66M USD
CapEx (TTM)306.52K USD
FCF Margin143.03%
FCF Yield3.24%
Net Debt10.08M USD
Net Debt/EBITDA12.44
Balance Sheet
Debt/Equity-1.10
Current Ratio0.96
Quick Ratio0.92
Book Value/Sh-0.23 EUR
Cash/Share0.14 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.96.53M
Float18.11M
Insiders47.71%
Institutions0.00%
Technical
SMA 500.6954 (-22.8%)
SMA 2001.011 (-46.9%)
Beta1.20
S&P 52W Chg14.58%
Avg Vol (30d)264.63K
Avg Vol (10d)311.44K
Technical Indicators
RSI (14)24.9
MACD-0.0329
MACD Signal-0.0150
MACD Hist.-0.0179
BB Upper0.7961 EUR
BB Middle0.6827 EUR
BB Lower0.5693 EUR
BB Width33.21%
ATR (14)0.0348 EUR
Vol Ratio (20d)2.69x